Dr. Stuart Liberman, MD
What this data tells you about Dr. Liberman
Dr. Stuart Liberman is an urology physician in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Liberman performed 2,443 Medicare services across 1,848 unique beneficiaries.
Between the years covered by Open Payments, Dr. Liberman received a total of $3,165 from 19 pharmaceutical and/or device companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Liberman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis | 743 | $2 | $9 |
| Office visit, established patient (20-29 min) | 486 | $62 | $180 |
| Office visit, established patient (30-39 min) | 179 | $89 | $255 |
| Diagnostic exam of bladder and urethra using an endoscope | 141 | $170 | $485 |
| New patient office visit (45-59 min) | 109 | $125 | $334 |
| New patient office visit (30-44 min) | 108 | $78 | $225 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 98 | $135 | $1,067 |
| Bladder ultrasound after voiding | 69 | $8 | $32 |
| Ultrasound scan of pelvic region through rectum | 61 | $99 | $262 |
| Simple insertion of temporary bladder tube | 54 | $42 | $123 |
| Instillation of anti-cancer drug into bladder | 54 | $66 | $175 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 51 | $40 | $104 |
| Imaging of urinary tract following injection of a contrast agent | 45 | $19 | $50 |
| Electronic assessment of bladder emptying | 43 | $8 | $29 |
| Biopsy of prostate gland | 37 | $184 | $482 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $25 | $66 |
| Office visit, established patient (10-19 min) | 22 | $34 | $112 |
| Insertion of stent in ureter using an endoscope | 18 | $98 | $314 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 16 | $25 | $268 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 16 | $218 | $583 |
| Shock wave crushing of kidney stones | 15 | $438 | $1,158 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 14 | $257 | $722 |
| Insertion of device into abdomen with pressure and urine flow rate study | 14 | $136 | $381 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 14 | $248 | $638 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 12 | $166 | $425 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Liberman is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Liberman experienced with automated urinalysis?
Does Dr. Liberman receive payments from pharmaceutical companies?
How do Dr. Liberman's costs compare to other urology physicians in Melbourne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology